|
Volumn 1, Issue 1, 2002, Pages 31-49
|
Targeting the JNK pathway for therapeutic benefit in CNS disease.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ENZYME INHIBITOR;
MITOGEN ACTIVATED PROTEIN KINASE;
STRESS ACTIVATED PROTEIN KINASE;
ANIMAL;
DEGENERATIVE DISEASE;
DRUG ANTAGONISM;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
ENZYMOLOGY;
HUMAN;
METABOLISM;
METHODOLOGY;
PHYSIOLOGY;
REVIEW;
SIGNAL TRANSDUCTION;
SYNTHESIS;
ANIMALS;
DRUG DELIVERY SYSTEMS;
ENZYME INHIBITORS;
HUMANS;
JNK MITOGEN-ACTIVATED PROTEIN KINASES;
MITOGEN-ACTIVATED PROTEIN KINASES;
NEURODEGENERATIVE DISEASES;
SIGNAL TRANSDUCTION;
|
EID: 0009521251
PISSN: 1568007X
EISSN: None
Source Type: Journal
DOI: 10.2174/1568007023339472 Document Type: Review |
Times cited : (77)
|
References (205)
|